New Delhi, May 12 -- GLP-1 receptor agonists like semaglutide and tirzepatide have changed the conversation around weight management. For individuals using these medications, appetite suppression is often significant. Meals feel smaller. Hunger signals arrive less frequently. That reduced intake, while central to how these medications work, creates a nutritional challenge that doesn't get discussed enough: when you're eating considerably less, what you choose to eat matters considerably more.

Protein sits at the top of that priority list, and for good reason. During periods of caloric deficit, the body draws on both fat and muscle for energy. "Without adequate protein intake, muscle loss accelerates, metabolism slows, and the physical ou...